In this case, it was shown that women reporting pain had higher levels of C-reactive protein and interleukin-13 and more interference of pain with quality of life, together with a higher incidence of depression and sleep disorders, in comparison with the same parameters evaluated in women without pain. This evidence concerns the gene CRP and depressive disorder.